abstract data plots on a screen

Unlocking Clinical Monitoring Success: A Decade of Insights

1 minute read

Published: October 26th, 2023

For over a decade, Phastar has been at the forefront of the clinical monitoring domain, delivering tailored solutions to numerous pharmaceutical and biotech companies. Our extensive experience spans more than 20+ therapeutic areas and over 100 distinct clinical trials, revealing recurring challenges in clinical monitoring

In this article, we shed light on why we advocate for transitioning to a modern data analytics platform as the key to achieving your clinical monitoring objectives.

Complete the form below to download the article

Related articles

Transforming Clinical Development Through Exploration, Automation, and Prediction with AI

Transforming Clinical Development Through Exploration, Automation, and Prediction with AI

September 23rd, 2026 1 minute read

Artificial intelligence is transforming how life sciences organizations generate evidence, design clinical trials, an...

Building Effective Partnerships Between Biotechs and CROs to Advance Clinical Development 

Building Effective Partnerships Between Biotechs and CROs to Advance Clinical Development 

July 21st, 2026 1 minute read

The biotech industry is evolving rapidly, with emerging companies leading the charge in clinical development. As outs...

Flexible Dose-Finding in Early-Phase Oncology Combination Studies Enabling Mid-Trial Dose Insertions to Improve Dose Recommendations

Flexible Dose-Finding in Early-Phase Oncology Combination Studies Enabling Mid-Trial Dose Insertions to Improve Dose Recommendations

April 2nd, 2026 1 minute read

Early-phase oncology combination trials often assume the optimal dose is already included in the dosing gri...